Norman C. Selby - Jun 16, 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Director
Signature
/s/Seth A. Tasker as attorney-in-fact for Norman C. Selby
Stock symbol
INFI
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 08:37 PM
Previous filing
Jun 11, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +45K $0.00 45K Jun 16, 2022 Common Stock 45K $0.68 Direct F1
transaction INFI Stock Option(right to buy) Award $0 +10K $0.00 10K Jun 16, 2022 Common Stock 10K $0.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
F2 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as Lead Independent Director of the issuer's Board of Directors.

Remarks:

Exhibit 24 - Limited Power of Attorney